An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...

A majority (91%) of HIV patients who received care through the Ryan White HIV/AIDS Program were virally suppressed in 2024, according to a new Health Resources and Services Administration (HRSA) ...

Patients with HIV face a significantly higher 30-day readmission risk following hospitalization for HF or AMI compared with those without HIV.

A randomized clinical trial led by Johns Hopkins researchers finds that giving patients a next-day HIV viral load (VL) test ...

The National AIDS and STI Control Programme (NASCOP) and the Health NGOs Network (HENNET) have issued a strong warning ...

The court filing follows a CNBC investigation that detailed how these third-party vendors have spread across U.S.

Known as the City of Hope patient, he is the fourth patient in the world and the oldest to go into long-term remission of HIV without antiretroviral therapy (ART) for over a year after receiving stem ...

In patients with HIV infection on rifampicin TB therapy, twice-daily bictegravir/emtricitabine/tenofovir alafenamide results ...

Jim’s Courage’ shares the story of late San Diego resident Jim Dunn and his role in research aiming to find a cure for HIV ...

ViiV Healthcare tapped real patients to help drill down into Dovato’s unique selling point to help promote the HIV drug—and it took that message far and wide with a boost in TV ad spending during ...

A University of Virginia-led team of researchers has made a discovery that may change sepsis treatment for patients in Africa ...

Research into this new way of treating HIV is only beginning. When it was first named in 1983, HIV was thought to be a death sentence. The virus replicated rapidly in the people it infected because ...